QuiVad

Home / France / Eurofins Scientific SE

Eurofins Scientific SE

Short position disclosed on September 21, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 12.19% on July 1, 2019. The shaded band matches the twelve months of the first chart.

November 1, 2012 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
AQR Capital Management, LLC0.50%newSeptember 21, 2026

On the other side: the funds that hold Eurofins Scientific SE Titelia

Follow by RSS

Get the moves on Eurofins Scientific SE by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

422 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 30, 2024AKO Capital LLP1.09%March 6, 2025
August 16, 2024AKO Capital LLP1.12%March 6, 2025
July 29, 2024AKO Capital LLP1.08%March 6, 2025
July 29, 2024Kintbury Capital LLP0.47%July 31, 2024
July 25, 2024AKO Capital LLP1.13%March 6, 2025
July 16, 2024AKO Capital LLP1.21%March 6, 2025
July 3, 2024AKO Capital LLP1.13%March 6, 2025
June 25, 2024AKO Capital LLP1.05%March 6, 2025
June 24, 2024AKO Capital LLP1.11%March 6, 2025
June 18, 2024Blackrock Investment Management (UK) Limited0.67%July 30, 2025
June 18, 2024Kintbury Capital LLP0.51%July 31, 2024
June 11, 2024AKO Capital LLP1.40%March 6, 2025
June 6, 2024AKO Capital LLP1.34%March 6, 2025
May 28, 2024Greenvale Capital LLP0.44%May 30, 2024
May 20, 2024Blackrock Investment Management (UK) Limited0.70%July 30, 2025
May 16, 2024AKO Capital LLP1.29%March 6, 2025
May 15, 2024AKO Capital LLP1.38%March 6, 2025
April 26, 2024AKO Capital LLP1.41%March 6, 2025
April 10, 2024Blackrock Investment Management (UK) Limited0.69%July 30, 2025
April 2, 2024Greenvale Capital LLP0.50%May 30, 2024
March 14, 2024AKO Capital LLP1.30%March 6, 2025
March 6, 2024Greenvale Capital LLP0.49%March 8, 2024
February 29, 2024AKO Capital LLP1.21%March 6, 2025
February 27, 2024Greenvale Capital LLP0.54%March 8, 2024
February 26, 2024Greenvale Capital LLP0.75%March 8, 2024
February 23, 2024AKO Capital LLP1.10%March 6, 2025
February 6, 2024AKO Capital LLP1.01%March 6, 2025
February 2, 2024AKO Capital LLP0.92%March 6, 2025
January 29, 2024Greenvale Capital LLP0.67%March 8, 2024
January 25, 2024Greenvale Capital LLP0.75%March 8, 2024
January 3, 2024AKO Capital LLP0.80%March 6, 2025
December 13, 2023AKO Capital LLP0.72%March 6, 2025
November 23, 2023AKO Capital LLP0.61%March 6, 2025
November 16, 2023Greenvale Capital LLP0.81%March 8, 2024
November 15, 2023Blackrock Investment Management (UK) Limited0.73%July 30, 2025
November 15, 2023Marshall Wace LLP0.49%November 17, 2023
November 13, 2023Greenvale Capital LLP0.71%March 8, 2024
November 13, 2023Marshall Wace LLP0.50%November 17, 2023
November 9, 2023Marshall Wace LLP0.49%November 13, 2023
November 2, 2023Greenvale Capital LLP0.60%March 8, 2024
October 23, 2023Marshall Wace LLP0.57%November 13, 2023
October 20, 2023Marshall Wace LLP0.60%November 13, 2023
October 20, 2023AKO Capital LLP0.59%March 6, 2025
October 20, 2023Greenvale Capital LLP0.57%March 8, 2024
October 19, 2023AKO Capital LLP0.66%March 6, 2025
October 18, 2023Marshall Wace LLP0.59%November 13, 2023
October 17, 2023Blackrock Investment Management (UK) Limited0.61%July 30, 2025
October 17, 2023Marshall Wace LLP0.60%November 13, 2023
October 16, 2023AKO Capital LLP0.76%March 6, 2025
September 28, 2023AKO Capital LLP0.81%March 6, 2025

Download 422 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in France

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Eurofins Scientific SE, source AMF, data as at September 21, 2026, https://www.quivad.com/action/eurofins-scientific-se?page=2